NeuroSense CMO Ferenc Tracik steps down, effective April 27
PUBT · 04/24 13:20
Share
Listen to the news
- NeuroSense Therapeutics said Chief Medical Officer Ferenc Tracik will step down effective April 27, 2026.
- Tracik will continue to support NeuroSense as an independent adviser.
- Advisory work will focus on clinical development and medical strategy for PrimeC, including preparation for an upcoming Pre-NDS meeting with Health Canada.
- Departure was not tied to any disagreement over operations, policies, or practices.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Neurosense Therapeutics Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-047292), on April 24, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending